in the first quarter thanks to higher demand. It pulled in $20.7 billion in sales last quarter for profits of $2.30 per share. In an earnings release, the company said that sales of consumer products like Tylenol and Zyrtec rose nearly 10% as consumers stocked up on over-the-counter drugs to reduce fever and other symptoms associated with COVID-19.
Johnson & Johnson, which has a market cap of $387 billion, announced in March that it has chosen a leading vaccine candidate for the virus; it anticipates starting human trials by September of this year. Chief scientific officer Paul Stoffels told ABC’s “The Week” that the company is aiming to deliver
Я верю в лучшее
Drug pushers. Yrumps beloved Dow needs speculative hype
How awesome that some companies are making huge monies on this COVID19 thingy... 🤑
대한민국 최근 뉴스, 대한민국 헤드 라인
Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.
출처: WSJ - 🏆 98. / 63 더 많은 것을 읽으십시오 »